Immunis, Inc., a private biotech and a pioneering force in cellular secretome therapeutics, is delighted to share photos from the 2024 Longevity Investors Lunch In Davos, Switzerland (hosted by Longevity Investors Conference). This prestigious event brings together prominent leaders in biotechnology, investment, and innovation to discuss recent advancements in the longevity sector. Immunis’ Chairman, Dr. Hans Keirstead, was an invited speaker and panelist for the conference.